Molecular Techniques for Blood and Blood Product Screening

Mostrar otras versiones (2)

Blood product safety is a high priority for manufacturing industries, hospitals, and regulatory agencies. An important step in ensuring safety is the screening of donated blood for infectious diseases. Molecular technologies for screening infectious diseases have improved remarkably over the years....

Descripción completa

Detalles Bibliográficos
Autor principal: Hu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120069/
http://dx.doi.org/10.1007/978-3-319-95111-9_2
_version_ 1783514894664990720
author Hu, Yuan
author_facet Hu, Yuan
author_sort Hu, Yuan
collection PubMed
description Blood product safety is a high priority for manufacturing industries, hospitals, and regulatory agencies. An important step in ensuring safety is the screening of donated blood for infectious diseases. Molecular technologies for screening infectious diseases have improved remarkably over the years. Molecular biological assay significantly reduced the risk of transfusion-transmitted infections. Unlike previous methods, molecular technologies for screening infectious diseases are specific, efficient, easy to use, and economical. A new era in molecular biology is coming to the field of blood safety.
format Online
Article
Text
id pubmed-7120069
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-71200692020-04-06 Molecular Techniques for Blood and Blood Product Screening Hu, Yuan Advanced Techniques in Diagnostic Microbiology Article Blood product safety is a high priority for manufacturing industries, hospitals, and regulatory agencies. An important step in ensuring safety is the screening of donated blood for infectious diseases. Molecular technologies for screening infectious diseases have improved remarkably over the years. Molecular biological assay significantly reduced the risk of transfusion-transmitted infections. Unlike previous methods, molecular technologies for screening infectious diseases are specific, efficient, easy to use, and economical. A new era in molecular biology is coming to the field of blood safety. 2018-11-10 /pmc/articles/PMC7120069/ http://dx.doi.org/10.1007/978-3-319-95111-9_2 Text en © Springer Nature Switzerland AG 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Hu, Yuan
Molecular Techniques for Blood and Blood Product Screening
title Molecular Techniques for Blood and Blood Product Screening
title_full Molecular Techniques for Blood and Blood Product Screening
title_fullStr Molecular Techniques for Blood and Blood Product Screening
title_full_unstemmed Molecular Techniques for Blood and Blood Product Screening
title_short Molecular Techniques for Blood and Blood Product Screening
title_sort molecular techniques for blood and blood product screening
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120069/
http://dx.doi.org/10.1007/978-3-319-95111-9_2
work_keys_str_mv AT huyuan moleculartechniquesforbloodandbloodproductscreening

Ejemplares similares